Cells can then be exposed to neurotoxins to promote the pathogenesis of AD or PD, or they can be genetically modified to overexpress APP or Tau to mimic AD [145], or α-syn to mimic PD ([146]. This evidence concerns the gene MAPT and Parkinson disease.